A current model for predicting the risk of cardiovascular diseases in patients with type 2 diabetes mellitus

被引：0
|
作者：
Biryukova, E. V. [1 ]
机构：
[1] Moscow State Univ Med & Dent, Minist Hlth & Social Dev Russia, Moscow, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2012年 / 84卷 / 10期
关键词：
type 2 diabetes mellitus; ADVANCE trial; cardiovascular risk prediction scale; sugar-lowering therapy; BLOOD-GLUCOSE CONTROL; OUTCOMES; COMPLICATIONS; PREVALENCE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a severe progressive disease complicating the development of micro- and macrovascular complications that result in early disability, including that in able-bodied persons, a reduction in the patients' life, and its worse quality. The author discusses the new scale developed according to the results of the ADVANCE trial for predicting the cardiovascular risk in patients with T2DM which may be used widely in these patients to estimate the risk of cardiovascular events and as a tool to assist in determining the intensity of treatment. She considers current approaches to treating T2DM, by using the results of the ADVANCE trial.
引用
收藏
页码：98 / 102
页数：5
相关论文
共 50 条
  • [41] A Risk Prediction Model for Cardiovascular Disease-Related Death in Patients With Type 2 Diabetes Mellitus
    Geba, Daniela
    Gandhi, Pranav
    Cordova, Jeanine
    Shetty, Sharash
    Williams, Brent
    CIRCULATION, 2018, 138
  • [42] Risk factors for cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients
    Semyatichko, E.
    Nemtsova, V.
    Feclina, I.
    JOURNAL OF NEUROLOGY, 2007, 254 : 110 - 110
  • [43] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [44] Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
    Cockcroft, JR
    Wilkinson, IB
    Evans, M
    McEwan, P
    Peters, JR
    Davies, S
    Scanlon, MF
    Currie, CJ
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (11) : 1463 - 1467
  • [45] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [46] CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME
    Millan, J.
    Garcia Calzado, C.
    Recarte, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 29 - 29
  • [47] Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
    Lorber, Daniel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 169 - 183
  • [48] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [49] Incidence of cardiovascular diseases and type-2-diabetes mellitus in patients with psychiatric disorders
    Bent-Ennakhil, Nawal
    Perier, Marie Cecile
    Sobocki, Patrik
    Gothefors, Dan
    Johansson, Gunnar
    Milea, Dominique
    Empana, Jean-Philippe
    NORDIC JOURNAL OF PSYCHIATRY, 2018, 72 (07) : 455 - 461
  • [50] Endocan is Related to Increased Cardiovascular Risk in Type 2 Diabetes Mellitus Patients
    Klisic, Aleksandra
    Kotur-Stevuljevic, Jelena
    Ninic, Ana
    METABOLIC SYNDROME AND RELATED DISORDERS, 2023, 21 (07) : 362 - 369
12345